Safety and efficacy of Enviva® PRO 202 GT (Bacillus amyloliquefaciens PTA‐6507, Bacillus amyloliquefaciens NRRL B‐50013 and Bacillus amyloliquefaciens NRRL B‐50104) for chickens for fattening, chickens reared for laying and minor poultry species for fattening and to point of lay

Abstract

The additive Enviva® PRO 202 GT is a preparation containing viable spores of three strains of Bacillus amyloliquefaciens. The additive is intended for use in feed for chickens for fattening, chickens reared for laying and minor poultry species for fattening and to point of lay at a minimum dose of 30 mg/kg feed, which corresponds to 7.5 × 107 CFU/kg complete feedingstuffs. B. amyloliquefaciens is considered by EFSA to be suitable for the qualified presumption of safety approach to establishing safety. As the identity of the active agents was established and the lack of toxigenic potential and of resistance to antibiotics of human or veterinary clinical significance demonstrated, the additive is presumed safe for the target species, consumers and the environment. Enviva® PRO 202 GT is non-irritant to skin and eyes and is not a dermal sensitiser. Given the proteinaceous nature of the additive, there is a potential for respiratory sensitisation, although the risk is low due the low dusting potential. Data from three trials provide evidence that the inclusion of Enviva® PRO 202 GT at the recommended dose has the potential to improve the performance of chickens for fattening. This conclusion extends to the additive when used with chickens reared for laying and is extrapolated to minor avian species for fattening and to point of lay when used at the same dose. The three active agents are compatible with narasin/nicarbazin, maduramicin ammonium, lasalocid A sodium, salinomycin sodium, monensin sodium, diclazuril, robenidine hydrochloride, decoquinate and semduramycin sodium and nicarbazin.